Align Technology, Inc. Stock

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 12:57:01 2024-05-23 pm EDT 5-day change 1st Jan Change
252.8 USD -3.19% Intraday chart for Align Technology, Inc. -7.35% -7.50%
Sales 2024 * 4.12B Sales 2025 * 4.51B Capitalization 19.66B
Net income 2024 * 536M Net income 2025 * 632M EV / Sales 2024 * 4.48 x
Net cash position 2024 * 1.2B Net cash position 2025 * 1.51B EV / Sales 2025 * 4.02 x
P/E ratio 2024 *
36.9 x
P/E ratio 2025 *
31.1 x
Employees 21,670
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.47%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.20%
1 week-6.31%
Current month-9.24%
1 month-17.82%
3 months-19.12%
6 months+16.77%
Current year-6.46%
More quotes
1 week
256.16
Extreme 256.155
274.70
1 month
256.16
Extreme 256.155
327.49
Current year
250.28
Extreme 250.28
335.40
1 year
176.34
Extreme 176.34
413.20
3 years
172.05
Extreme 172.05
737.45
5 years
127.88
Extreme 127.88
737.45
10 years
43.27
Extreme 43.27
737.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 15-05-31
Director of Finance/CFO 57 16-11-09
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 72 06-01-31
Chief Executive Officer 66 15-05-31
Director/Board Member 58 Dec. 04
More insiders
Date Price Change Volume
24-05-23 253.2 -3.02% 409 049
24-05-22 261.1 -1.10% 461,079
24-05-21 264 -1.28% 502,755
24-05-20 267.4 -1.50% 822,271
24-05-17 271.5 -0.75% 591,155

Delayed Quote Nasdaq, May 23, 2024 at 09:58 am EDT

More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows: - clear aligners (82.8%): sold under the brand name Invisalign; - intra-oral scanners (17.2%): iTero. The group also offers scanner services. Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
261.1 USD
Average target price
340.7 USD
Spread / Average Target
+30.47%
Consensus